Medication-overuse headache: epidemiology, diagnosis and treatment
Open Access
- 6 February 2014
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Drug Safety
- Vol. 5 (2), 87-99
- https://doi.org/10.1177/2042098614522683
Abstract
Medication-overuse headache (MOH) is one of the most common chronic headache disorders and a public health problem with a worldwide prevalence of 1–2%. It is a condition characterized by chronic headache and overuse of different headache medications, and withdrawal of the overused medication is recognised as the treatment of choice. However, the strategy for achieving withdrawal is, at present, based on expert opinion rather than scientific evidence, partly due to the lack of randomised controlled studies. This narrative review investigates different aspects of epidemiology, diagnosis, risk factors and pathogenesis as well as management for MOH. We suggest that the first step in the treatment of MOH should be carried out in general practice and should focus primarily on detoxification. For most patients, both prevention and follow up after detoxification can also be performed in general practice, thus freeing resources for referral of more complicated cases to headache clinics and neurologists. These suffering patients have much to gain by an earlier treatment-focused approach lower down on the treatment ladder.Keywords
This publication has 141 references indexed in Scilit:
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2013
- Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headacheThe Journal of Headache and Pain, 2012
- Dependence scores predict prognosis of medication overuse headache: A prospective cohort from the Akershus study of chronic headachePain, 2012
- Management of primary chronic headache in the general population: the Akershus study of chronic headacheThe Journal of Headache and Pain, 2011
- Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group studyThe Journal of Headache and Pain, 2011
- Medication overuse headache: a critical review of end points in recent follow-up studiesThe Journal of Headache and Pain, 2010
- The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headachePain, 2010
- A narrative review on the management of medication overuse headache: the steep road from experience to evidenceThe Journal of Headache and Pain, 2009
- Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphismThe Journal of Headache and Pain, 2009
- Epidemiology and comorbidity of headacheThe Lancet Neurology, 2008